Ascendis Pharma's Share Price and Pipeline Progress: A Valuation Analysis

Ascendis Pharma's share price has outpaced its fundamentals after recent pipeline progress news. The stock closed at $222.15 with returns of 4.2% over the past month and 83.8% over the past year. Our valuation checks give Ascendis Pharma a score of 4 out of 6, indicating a discounted share price. Our DCF analysis suggests the shares trade at a 75.7% discount to the estimated intrinsic value of $915.22 per share.